Aktis Oncology, Inc. (AKTS)
About Aktis Oncology, Inc.
Aktis Oncology Inc is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The company specializes in developing targeted alpha radiopharmaceuticals for solid tumors such as breast, lung, colorectal, bladder, and liver cancers. Its pipeline products include AKY-1189 and AKY-2519, focusing on solid tumors. The company has one operating and reportable segment focused on the research and development of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers. The company generates revenue from Collaboration agreement.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2026
- $3.2M
- Net income
- -$18.3M
- Total assets
- $576.8M
- Market cap
- $1.3B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $1.3B
- Shares outstanding
- 80.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jan 9, 2026
Aktis Oncology, Inc. (AKTS) Stock Price
- Reported a net loss of $18.3M in FY2026.
- Trading 49% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Aktis Oncology, Inc..
Write a review
News about Aktis Oncology, Inc.
News & sentiment via Polygon.io
Aktis Oncology, Inc.: frequently asked questions
Is Aktis Oncology, Inc. an American company?
Aktis Oncology, Inc. is a US-based company headquartered in Boston, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Aktis Oncology, Inc. headquartered?
Aktis Oncology, Inc. is headquartered in Boston, Massachusetts, United States.
Is Aktis Oncology, Inc. publicly traded?
Yes — Aktis Oncology, Inc. is a publicly traded company. Its stock trades under the ticker symbol AKTS on the NASDAQ.
What does Aktis Oncology, Inc. do?
Aktis Oncology, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
